Colitis After CAR T-Cell Therapy for Refractory Large B-Cell Lymphoma Responds to Anti-Integrin Therapy.

Hashim, Ahmed; Patten, Piers E M; Kuhnl, Andrea; Ooft, Marc L; Hayee, Bu'Hussain; Sanderson, Robin

Hashim, Ahmed; Patten, Piers E M; Kuhnl, Andrea; Ooft, Marc L; Hayee, Bu'Hussain; Sanderson, Robin.

Afiliación

Hashim A; Department of Gastroenterology, King's College Hospital, London, United Kingdom.
Patten PEM; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.
Kuhnl A; Department of Haematology, King's College Hospital, London, United Kingdom.
Ooft ML; Department of Haematology, King's College Hospital, London, United Kingdom.
Hayee B; Department of Pathology, King's College Hospital, London, United Kingdom.
Sanderson R; Department of Gastroenterology, King's College Hospital, London, United Kingdom.

Inflamm Bowel Dis ; 27(4): e45-e46, 2021 03 15.

Article en En | MEDLINE | ID: mdl-33252123

Asunto(s)

Colitis; Inmunoterapia Adoptiva/efectos adversos; Integrinas/antagonistas & inhibidores; Linfoma de Células B Grandes Difuso; Colitis/etiología; Humanos; Linfoma de Células B Grandes Difuso/tratamiento farmacológico

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Integrinas / Inmunoterapia Adoptiva / Linfoma de Células B Grandes Difuso / Colitis Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Inflamm Bowel Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google